Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
CA 2026642 A1 · Owner: Aberg, A. K. Gunnar · Inventors: Ferrer, Patricia; Aberg, A. K. Gunnar; Ondetti, Miguel A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
HA512, Abstract, METHOD FOR STABILIZING OR CAUSING REGRESSION OF ATHEROSCLEROSIS IN CORONARY ARTERIES EMPLOYING AN ACE INHIBITOR, A method is provided for slowing the progression of atherosclerosis in coronary arteries in hypertensive or normotensive patients and reducing or eliminating atherosclerotic lesions in such patients in a mammalian species by administering an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 1, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 1, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 1, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.